Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 166

Results For "science"

2239 News Found

Ascletis Pharma completes patient enrollment in clinical for cure of HIV infection
Drug Approval | September 16, 2022

Ascletis Pharma completes patient enrollment in clinical for cure of HIV infection

The objective of this study is to evaluate the efficacy of ASC22 (Envafolimab) combined with Chidamide on the viral reservoirs of latently infected cells in HIV patients.


Alkem Laboratories appoints Srinivas Singh as Executive Director
People | September 15, 2022

Alkem Laboratories appoints Srinivas Singh as Executive Director

He holds a Bachelor’s Degree in Science and has joined the company in 2012 and has over 10 years of experience in pharmaceutical industry


Zydus receives final approval from USFDA for Lenalidomide Capsules
Drug Approval | September 15, 2022

Zydus receives final approval from USFDA for Lenalidomide Capsules

The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India


AstraZeneca launches up-skilling program iPHARMACY
News | September 15, 2022

AstraZeneca launches up-skilling program iPHARMACY

The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala


Dr. Jaidev Rajpal appointed MD & CEO of Jubilant Generics
People | September 15, 2022

Dr. Jaidev Rajpal appointed MD & CEO of Jubilant Generics

He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets


Zydus receives final approval from USFDA for Cariprazine Capsules
Drug Approval | September 15, 2022

Zydus receives final approval from USFDA for Cariprazine Capsules

Cariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder


Merck invests € 130 million + to strengthen manufacturing capabilities in France
News | September 10, 2022

Merck invests € 130 million + to strengthen manufacturing capabilities in France

Investment further strengthens Merck's "Big 3," the key drivers for increasing Group sales to approximately € 25 billion by 2025


Vandemark gets investment from SK Capital with Comvest partners
News | September 09, 2022

Vandemark gets investment from SK Capital with Comvest partners

SK Capital’s investment will serve as a catalyst for a new strategic direction as the Company seeks to deepen and expand its presence in fine chemistries for the global life science market.


We can create Seva Bhav by donating organs...: Dr. Mandaviya
News | September 09, 2022

We can create Seva Bhav by donating organs...: Dr. Mandaviya

Despite having rich knowledge and defined responsibility, there has been less than expected response towards organ donation from our citizens


Healthcare sector is expected to reach US $50 bn by 2025
News | September 08, 2022

Healthcare sector is expected to reach US $50 bn by 2025

Healthcare has become more focused on innovation and technology over the past two years and 80% of healthcare systems are aiming to increase their investment in digital healthcare tools in the coming five years